Virtual Medicinal Product (VMP) - Dapagliflozin 5mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Dapagliflozin 5mg tablets Start Date 19-11-2012 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
A10BK01
BNF Start Date End Date
Current BNF 06010203 Start Date 04-04-2022 End Date
Previous BNF 06010203 Start Date 21-05-2013 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39689911000001109 26-05-2021
703679006 01-10-2014 25-05-2021
21635211000001102 19-11-2012 30-09-2014

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Dapagliflozin propanediol monohydrate Based on Base Substance Dapagliflozin 5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet 3659 Part VIIIA Category C
30 tablet